| [return to list] |
|
Adrian
R.L.
Gear
Degree(s): D.Phil. Graduate School: Pembroke Coll, Oxford (UK) Primary Appointment: Professor of Biochemistry and Molecular Genetics Research Interests: Blood-platelet function; Cardiovascular disease; Inflammation Email Address: alg4p@virginia.edu |
|
Biomedical Sciences Graduate Program(s) Research Description Overall Research Description:
Blood platelets are essential for normal blood clotting, but when overactive,
can contribute to heart attacks and strokes. Understanding regulation of platelet
function is therefore an important aim for developing effective ways to modulate
their over-activity in cardiovascular disease. The research in our laboratory
is directed towards two main areas. The first involves understanding biochemical mechanisms that link platelet
activation by agents like ADP, thrombin, chemokines and collagen, to the participation
of these cells in clot formation and wound healing. The fundamental biochemical
and structural events in platelet function involve specific interactions of
these compounds with receptors on the plasma membrane, which then trigger major
responses inside the cell. Dramatic alterations in cell morphology are associated
with these biochemical changes; long pseudopodia are extended, intracellular
granules are secreted and platelets stick to each other (aggregation) or to
molecules such as collagen at the site of a wound (adhesion). The second area relates to the roles of blood platetets in disease. Two themes
are being studied: the first involves how blood lipids such as oxidized low-density
lipoprotein (ox-LDL), are involved in causing heart attacks or strokes. The
second area targets how specific toxins such as endotoxin (lipopolysaccharide,
or LPS) or shiga toxin (STXs, associated with the 'hamburger disease') may stimulate
blood clotting and cardiovascular problems. Specific research questions are as follows: 1) How is platelet function controlled by alterations in the synthesis and
degradation of cyclic AMP and cyclic GMP, including the involvement of new drugs
such VIOXX and CELEBREX and nitric oxide? |